Pfizer says penicillin injection may soon be in short supply

2023-06-14
Pfizer has notified the FDA that there may be an impending shortage of penicillin, citing an increase in syphilis infections and other shortages.
In a letter posted to the FDA’s website and dated Monday, the pharma said there is “limited supply” and an “impending stock out situation” for prefilled Bicillin L-A and Bicillin C-R syringes, which are also used to treat pneumonia, strep throat and other bacterial infections. To alleviate the possible shortage, Pfizer said it’s prioritizing the production of Bicillin L-A prefilled syringes, according to a Pfizer spokesperson.
Pfizer says penicillin injection may soon be in short supply
Preview
来源: EndPoints
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters
SIGN UP
LOG IN
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。